PlayOn11 - Where Fans Become Winners
UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative me...

BUSINESS NEWS April 17, 2026

UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative medicine and advanced therapies," the company said.

3 views 0 likes 0 comments
Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative medicine and advanced therapies," the company said.

Author: Fierce Biotech

Read Original Article

Related News

Top Categories